International surveillance of antimicrobial resistance in Europe: now we also need to monitor antibiotic use

Abstract

With travel and trade within the European Union (EU) increasing over the years, the risk of dissemination of (resistant) pathogens grows. Many studies have shown that there is a growing problem with antimicrobial resistance. For example, methicillin resistant Staphylococcus aureus (MRSA) was initially largely a problem of hospitals, but it is now increasingly reported as a community acquired infection. Certain strains have been shown to spread between European countries. Antimicrobial resistance may result in prolonged hospital stay, higher costs, and higher morbidity or even mortality.